Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 GeneticVariation disease BEFREE We present this case to add to the literature on the rare diagnosis of atypical Krabbe disease due to saposin A deficiency, to report a novel presumed pathogenic variant within PSAP, and to suggest that individuals with saposin A deficiency may have elevated levels of psychosine, similar to children with classic Krabbe disease due to GALC deficiency. 31439510 2020
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 Biomarker disease GENOMICS_ENGLAND Advantages and pitfalls of an extended gene panel for investigating complex neurometabolic phenotypes. 27604308 2016
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 Biomarker disease GENOMICS_ENGLAND A practical approach to diagnosing adult onset leukodystrophies. 24357685 2014
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 Biomarker disease GENOMICS_ENGLAND Non-neuronopathic Gaucher disease due to saposin C deficiency. 17919309 2007
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 Biomarker disease GENOMICS_ENGLAND A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. 15773042 2005
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 GeneticVariation disease BEFREE A mutation in the saposin A coding region of the prosaposin gene in an infant presenting as Krabbe disease: first report of saposin A deficiency in humans. 15773042 2005
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 Biomarker disease GENOMICS_ENGLAND A non-glycosylated and functionally deficient mutant (N215H) of the sphingolipid activator protein B (SAP-B) in a novel case of metachromatic leukodystrophy (MLD). 10682309 2000
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 CausalMutation disease CLINVAR
Entrez Id: 5660
Gene Symbol: PSAP
PSAP
0.620 Biomarker disease CTD_human
Entrez Id: 2581
Gene Symbol: GALC
GALC
0.010 Biomarker disease BEFREE Human globoid cell leukodystrophy owing to saposin A deficiency might be anticipated and should be suspected in human patients with a late-onset leukodystrophy with normal galactosylceramidase activity when other possibilities are also excluded. 14572137 2003